Swetha Narala, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 103 Little Mountain Rd, Ninety Six, SC 29666 Phone: 864-543-3515 Fax: 864-543-2973 |
News Archive
MabCure, Inc., a biotechnology company that has developed a series of highly specific monoclonal antibodies (MAbs) to combat various types of cancers, has reached another development milestone, with the creation of its MAbs against Colorectal Cancer (CRC). After further characterization the company plans to explore the utility of these MAbs in terms of both the early diagnosis of CRC (in blood or feces specimens), as well as imaging agents for detecting micrometastatic disease during surgery and the detection of cancerous polyps during colonoscopy.
Johnson & Johnson today announced sales of $16.5 billion for the second quarter of 2012, a decrease of 0.7% as compared to the second quarter of 2011. Operational results increased 3.5% and the negative impact of currency was 4.2%.
Pathway Genomics, a genetic testing laboratory on the forefront of bringing physicians a broad genetic testing portfolio covering a wide range of diseases, announces the pending launch of its inherited cancer panel with BRCA1 and BRCA2.
A study of over 500 men born in the early 70s in Dunedin reveals that the costs associated with antisocial behaviour may be much higher than previously thought. The research led by scientists from the MRC Social, Genetic and Developmental Psychiatry Centre based at the Institute of Psychiatry, King's College London is published in Archives of General Psychiatry.
› Verified 8 days ago